Chicago Partners Investment Group LLC Invests $340,000 in HCA Healthcare, Inc. (NYSE:HCA)

Chicago Partners Investment Group LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 942 shares of the company's stock, valued at approximately $340,000.

A number of other large investors also recently modified their holdings of HCA. GAMMA Investing LLC lifted its stake in shares of HCA Healthcare by 40,527.3% in the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after acquiring an additional 1,699,713 shares during the last quarter. Pacer Advisors Inc. increased its holdings in HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the period. Goldman Sachs Group Inc. increased its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after purchasing an additional 587,036 shares during the period. Barclays PLC increased its holdings in HCA Healthcare by 85.7% in the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company's stock valued at $318,727,000 after purchasing an additional 489,916 shares during the period. Finally, Two Sigma Investments LP increased its holdings in HCA Healthcare by 12,016.0% in the fourth quarter. Two Sigma Investments LP now owns 467,437 shares of the company's stock valued at $140,301,000 after purchasing an additional 463,579 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 0.9%

NYSE HCA traded up $3.40 during trading hours on Thursday, hitting $393.86. The company's stock had a trading volume of 705,362 shares, compared to its average volume of 1,577,536. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company's 50-day simple moving average is $370.06 and its two-hundred day simple moving average is $350.57. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $92.16 billion, a PE ratio of 16.56, a price-to-earnings-growth ratio of 1.23 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter last year, the firm earned $5.50 EPS. The company's quarterly revenue was up 6.4% compared to the same quarter last year. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent analyst reports. Bank of America downgraded HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target for the company. in a report on Wednesday, July 16th. Truist Financial increased their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Wells Fargo & Company decreased their price target on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday. Finally, Stephens upgraded HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Nine investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $401.62.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.